R 0005/15 (Right to be heard II/EURO-CELTIQUE) of 29.05.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:R000515.20170529
- Date of decision
- 29 May 2017
- Case number
- R 0005/15
- Petition for review of
- T 1938/09 2015-03-09
- Application number
- 98906678.2
- IPC class
- A61K 9/70A61K 31/485A61F 13/00
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen and members (B)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Sustained analgesia achieved with transdermal delivery of buprenorphine
- Applicant name
- EURO-CELTIQUE S.A.
- Opponent name
- Hexal AG
Luye Pharma AG - Board
- -
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 112a(2)(c)European Patent Convention Art 112a(2)(d)European Patent Convention Art 113(1)European Patent Convention R 104(b)European Patent Convention R 106
- Keywords
- Right to be heard fundamental violation (no)
Omission to decide on a relevant request (no)
Other fundamental procedural defect (no) - Catchword
- -
- Cited cases
- G 0009/91R 0001/08R 0010/09R 0012/09R 0016/09R 0013/12R 0001/13R 0002/14R 0013/14T 2362/08
- Citing cases
- R 0006/21
Order
For these reasons it is decided that:
The petition for review is rejected as unallowable.